Latest Strategic Outlook News

BetMakers Technology Group has launched a $1 million Share Purchase Plan (SPP) at $0.10 per share, offering eligible shareholders in Australia and New Zealand a chance to increase holdings at a discount following a $12.5 million institutional placement.

BluGlass Limited has extended the closing date of its Share Purchase Plan to 18 June 2025 and introduced a New Commitment Offer to secure up to $1.5 million if initial subscriptions fall short of $6 million.

Astron Corporation is set to redomicile from Hong Kong to Australia, establishing a new Australian parent company and simplifying shareholder engagement. This move aims to align governance with local standards and boost investor confidence.

PointsBet’s board has unanimously dismissed Betr Entertainment’s acquisition proposal, reaffirming that MIXI Australia’s $1.20 per share cash offer remains the superior path forward for shareholders.

ENRG Elements Limited announces significant board reshuffle, appointing seasoned mining executives to key leadership roles while two directors resign.

Macarthur Minerals has clarified key details regarding its recent convertible note funding, confirming the counterparty is an independent entity and highlighting the need for shareholder approval before issuing shares on conversion.

Patronus Resources has reported encouraging results from its recent RC drilling campaign at the Iron King and Cardinia Gold Projects, confirming gold mineralisation and highlighting potential for resource expansion.

Robex Resources confirms steady progress on its Kiniero Gold Project in Guinea, maintaining schedule and budget for first gold production in late 2025.

Metgasco Ltd has successfully raised approximately $750,000 through a partially underwritten entitlement offer to fund a production uplift program targeting its Odin and Vali gas fields in the Cooper Eromanga Basin.

AnteoTech secures a significant purchase order from the Serum Institute of India, driving its Life Sciences unit toward a projected 130% sales increase in FY2025 despite some project delays.

Brazilian Rare Earths has successfully produced high-purity mixed-rare-earth carbonate and uranium yellowcake from its Monte Alto Project, marking a key milestone in its integrated supply chain ambitions.

Telix Pharmaceuticals showcased its global theranostic radiopharmaceutical portfolio, highlighting FDA approvals, clinical progress, and a robust commercial expansion plan at its 2025 Investor Day.